US venture capital investment in private biotechnology companies dipped to $1.05bn in the third quarter from $1.84bn in the second quarter, but venture funding in 2014 remains on track to beat the 2013 total and may exceed $5bn for the year – a total that hasn't been reached since 2008.
Venture capital funds invested nearly $4bn in biotech firms during the first nine months of 2014, according to the quarterly...
Welcome to Scrip
Create an account to read this article
Already a subscriber?